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Objective: The aim of this study was to investigate the influence of the antiproliferative agent 5-Fluo-
rouracil (5FU) over inhibition of spinal bone formation in an experimental rat model.
Methods: The study included 30 6-month-old Sprague-Dawley rats divided into 3 groups. Aggressive 
periosteal denuding was performed by scalpel to induce punctuate bleeding in the posterior elements 
of the L4-L5 vertebrae in the spontaneous fusion model. Spinous processes were fixated by wires and 
no graft substitute was applied. Adcon-L was applied in Group 1, single-touch technique 5FU in 
Group 2. Group 3 was the control group. Rats were sacrificed at 4 weeks and specimens acquired for 
histological examination.
Results: 5FU substantially inhibited fibroblast and inflammatory cell densities as well as bone forma-
tion compared to the control group. 5FU was considerably superior to Adcon-L with regard to inhibi-
tion of bone formation and inflammatory cells (p=0.0001).
Conclusion: 5FU can inhibit fusion, fibrosis and unwanted scar tissue in spinal surgery. We believe 
that after further studies on its local delivery dose, it can be used in humans for inhibition of unin-
tended fusion.
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In spinal surgery, with the exception of prosthetic im-
plants, fusion is a desired outcome in all but two pro-
cedures. Generally, surgical interventions on immature 
spines (<10 years of age) are not performed with the 
intent of achieving fusion. Observation of spinal decom-
pensation or short spinal height in fusions performed 
on young patients has indicated the need for non-fusion 
techniques. The main target of these techniques is to 
spare the spine from excessive deformation until the de-
finitive fusion procedure or adequate maturation of the 
spine. However, unintended spontaneous fusions associ-
ated with the surgical exposure of the immature spine 
may arise as even a periosteal scratch can generate fusion 
in an immature spine.[1-7] Fusion is also an undesired 
outcome in decompression surgery for the treatment of 
degenerative spinal disease. In degenerative spinal dis-
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eases which necessitate fusion and decompression, post-
operative restenosis may present a problem. Although 
not proven, the presence of a potential risk for restenosis 
is considered in cases in which osteogenetic agents such 
as bone morphogenetic protein (BMP) are used.[8-10]
Since spinal fusion is generally desired, many studies 
in the literature have focused on the negative influence 
on fusion of various drugs and prevention of this effect. 
Therefore, only a limited numbers of studies have been 
designed to create fusion inhibition. In the literature, 
studies evaluating the inhibition of fusion by application 
of local agents have assessed the impacts of fibrin sealant 
and Adcon-L.[10,11] Different opinions on the effects of 
fibrin sealant on fusion have been reported and studies 
have indicated a positive impact on fusion by holding the 
graft substitutes together.[12] Adcon-L is a biomaterial 
used for the inhibition of adhesion and fibrosis based 
on the theory that it prevents migration of proliferative 
cells to the lesion site. It has been shown to inhibit fu-
sion based on the same principle.[11] In recent decades, 
the classical antiproliferative agent 5-Fluorouracil (5FU) 
has been increasingly used for prevention of fibrosis in 
ophthalmological procedures and hand surgery. We hy-
pothesized that 5FU may be as effective as Adcon-L in 
the inhibition of spinal fusion. 
The aim of the present study was to investigate the 
inhibitory effect on spinal fusion of local application of 
5FU using a rat model.
Materials and methods
This study was conducted with approval of the Local 
Ethics Committee for Research on Animals of our in-
stitute.
Posterior spine exposure was performed on the tho-
racic region of two 2-week-old immature Sprague-Daw-
ley rats in order to simulate a valid model for spontane-
ous spinal fusion. Subperiosteal denuding was applied 
to all muscles using a scalpel. Animals were sacrificed 4 
weeks later. No osseous or fibrous proliferations were 
observed. For this reason, spinous process wiring was 
integrated to the procedure in an additional 2 imma-
ture rats in order to achieve a more proper spontane-
ous fusion model. However, optimum fixation was not 
achieved due to small posterior elements. Two 6-month-
old Sprague-Dawley rats were subjected to aggressive 
subperiosteal denuding and spinous process wiring. 
Wires were removed at the postoperative 4th week. This 
process was recognized as the study model after observa-
tion of significant proliferative changes when compared 
to the un-operated segments.
This study included 30 6-month-old Sprague-Daw-
ley rats, divided into 3 groups. Group 1 received Ad-
con-L (Adcon-L Adhesion Control Gel®; Gliatech Inc., 
Cleveland, OH, USA), Group 2 5FU (5-Fluorouracil®; 
Choongwae Pharma Corp., Seoul, South Korea) and 
Group 3 was the control group.
Following anesthesia with 10 mg/kg xylazine hydro-
chloride (Rompun®; Bayer AG, Leverkusen, Germany) 
and 40 mg/kg ketamine hydrochloride (Ketalar®; Ec-
zacibasi, Istanbul, Turkey), the operation site was shaved 
and prepared for the surgery under sterile conditions. Af-
ter the midline incision, posterior elements of the L4-L5 
lumbar spine were reached and muscles were denuded. 
During the denuding process, cautery was not used. The 
entire muscle tissue and bone periosteum were denuded 
by scraping with a scalpel until observation of punctate 
bleeding over the lamina. Wires of 0.3-mm thickness 
were used on the spinous processes for the L4-L5 fixa-
tion. In Group 1, 50 µl Adcon-L was applied using its 
own apparatus on the exposed posterior elements of the 
L4-L5 vertebrae. In Group 2, 5FU was applied on the 
vertebrae by a sponge with single-touch technique[13] for 
5 minutes following irrigation of the operation site with 
10 ml saline. Group 3 (control group) received only 10 
ml saline over the operation site.
Postoperative ambulatory activities and wound heal-
ing were monitored daily. None of the groups displayed 
neurological deficit, infection or difference in cutaneous 
healing. Rats were sacrificed by intravenous high-dose 
sodium pentothal (100 mg/kg) at postoperative 28 days 
and the entire lumbar vertebrae were excised en bloc 
through the former incision for histological examination. 
Vertebrae were fixed in a 10% formaldehyde solution 
and decalcified with 10% formic acid and 8% HCl for 2 
days. Sections of 5 µm thickness were prepared from the 
specimens and stained with hematoxylin-eosin (HE) 
and Masson’s trichrome (MT).
Cells were counted in 3 different fields of 3 sections 
for each subject. Similarly, inflammatory cells (polymor-
phonuclear cells, lymphocytes and monocytes) were 
counted under x400 magnification. He and Revel’s cri-
teria were used to calculate the density of the fibroblasts 
in the scar tissue.[14] New bone formation and neovas-
cularization were assessed microscopically according to 
the criteria of Emery et al.[15] (0-3: no new bone - maxi-
mum new bone, and 0-3: no neovascularization - maxi-
mum neovascularization) (Table 1). Preparations were 
histopathologically evaluated with regard to degree of 
scarring, inflammation, infection and Adcon-L resorp-
tion. 
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All data were analyzed using the Statistical Program 
for Social Science software v.10.0 (SPSS Inc., Chicago, IL, 
USA) with Kruskal-Wallis and Mann-Whitney U-tests. 
P values of less than 0.05 were considered significant.
Results
Ninety percent of new bone formation in the Adcon-L 
group was Grade 3 while 80% in the 5FU group was 
Grade 0 (Fig. 1) (Table 1). The majority of new bone 
formation in the control group was Grade 2 and 3. There 
was a statistically significant difference between the 5FU 
and control groups (p=0.0001). 
Fibroblast density was low in the Adcon-L and 5FU 
groups. According to the criteria of He and Revel,[14] 
both the Adcon-L and 5FU groups demonstrated 70% 
density for Grade 2 fibroblasts and 70% density for 
Grade 3 fibroblasts in the control group (Table 1). Fi-
broblast density was significantly reduced in the Ad-
con-L and 5FU groups compared to the control group 
(p=0.0001).
Inflammatory cell counts were elevated in the Adcon-
L group and decreased in the 5FU group. Average inflam-
matory cell count under x400 magnification was 11.7 in 
the Adcon-L group while it was 1.8 for the 5FU group 
and 5.9 for the control group (Fig. 1) (Table 1). There 
was a significant difference between the 5FU and control 
groups in terms of inflammatory cell density (p=0.0001). 
Assessment of the sections with regard to neovas-
cularization based on Emery et al.’s[15] criteria revealed 
a prevalence of Grade 2 neovascularization in all the 
groups with no intergroup difference (p=0.1140). None 
of the agents had a negative or positive effect over neo-
vascularization. Adcon-L was not completely resorbed 
in half of the subjects in the Adcon-L group. 
Discussion
The issue of spontaneous, or unintended, fusion, in spi-
nal surgery has been noted by many authors.[1-7] Osse-
ous bridging and excessive fibrous reaction can affect the 
spine and hinder mobility in cases of spontaneous fu-
sion.[16,17] Spontaneous fusion and fibrosis that hinders 
correction of the deformity and leads to crankshaft de-
formity have been reported in cases of Luque instrumen-
tation without fusion.[6,18] Although the increased capac-
ity for healing in immature spines is held responsible for 
spontaneous fusion, no significant change has been ob-
served in the number of reports involving spontaneous 
fusion despite recent precautionary steps, such as small 
skin incision, minimal muscle denuding, effective hemo-
stasis, wound site irrigation and use of the subfascial or 
subcutaneous method. Cahill et al. reported a spontane-
ous fusion rate of 89% in the spinal segments of 9 im-
mature patients undergoing definitive fusion surgery.[7]
Table 1. The 5FU Group shows significant difference with regard to inhibition of inflammatory cell density and new bone formation.
Groups  1 2 3 4 5 6 7 8 9 10 Average
New Bone Formation*           
 Adcon-L 3 3 3 3 3 3 3 3 2 3 
 5FU 0 0 2 0 0 3 0 0 0 0 
 Control 2 3 3 3 1 0 2 2 3 0 
Fibroblast density†           
 Adcon-L 161 129 175 138 117 69 134 113 76 103 121.5
 5FU 115 95 130 131 144 125 111 98 140 110 119.9
 Control 292 210 157 204 242 199 158 186 218 141 200.7
Inflammatory cell density‡           
 Adcon-L 4 15 4 5 15 25 15 2 20 12 11.7
 5FU 4 3 2 1 2 2 1 1 1 1 1.8
 Control 5 5 3 4 6 19 7 3 4 3 5.9
Neovascularization§           
 Adcon-L 2 2 2 2 2 3 2 2 2 2 
 5FU 1 2 2 2 1 2 2 2 2 2 
 Control 2 2 2 3 2 2 2 2 2 2 
*Semiquantitative assessment of the new bone formation was based on Emery et al.’s[15] criteria. 0: No new bone formation, 1: Minimal bone formation, 2: Mild 
bone formation, 3: Maximal bone formation. †Fibroblast count was performed in three different fields of three sections for each subject under x400 magnification 
and the average value of those counts was used. ‡Polymorphonuclear cells, lymphocytes, and monocytes were counted in three different fields of three sections for 
each subject under x400 magnification and the average value of those counts was used. §Assessment of neovascularization was based on Emery et al.’s[15] criteria. 
0: No neovascularization, 1: Minimal neovascularization, 2: Mild neovascularization, 3: Maximal neovascularization.
Only a small number of studies have investigated 
the inhibitory effect of pharmaceutical agents in spinal 
surgery. Zou et al.[11] reported that Adcon-L inhibited 
spontaneous fusion to a certain degree. In this experi-
mental study, following bilateral decortication of the 
transverse processes, the authors performed intertrans-
verse fusion by applying an autograft acquired from the 
iliac wing on one side, while using a mixture comprised 
of the same amount of autograft and Adcon-L on the 
other side. Since we believe that this model and other 
fusion models in different experimental studies do not 
simulate spontaneous fusion properly, we created a mod-
el in which no method that can trigger fusion or fibrosis 
other than aggressive denuding and spinous process wir-
ing was used. Fibrin glue, which generally acts as a car-
rier to hold the graft substitutes together, has also been 
used in the literature for similar purposes and is thought 
to prevent migration and distribution of graft materials 
and BMPs over areas where fusion is not desired.[9,10] 
However, fibrin glue enables fusion control rather than 
inhibits fusion and bears importance particularly with 
regard to decompressive surgery. 
The two agents used in our study have different mech-
anisms of action. The antiproliferative agent 5FU is a flu-
orinated pyrimidine analog used as a topical agent for the 
prevention of fibrosis after trabeculectomy and glaucoma 
filtration surgery.[19,20] It has also been shown in experi-
mental studies to reduce the fibrotic adhesions following 
tendon repairs.[21-23] The aim of the 5-minute long single-
touch method is to avoid the side effects of 5FU while ob-
taining the benefit of its antiproliferative properties. This 
technique does not lead to cell death but alters the metab-
olism and behavior of cells by affecting cellular mRNAs 
of the cytoskeleton and inhibiting the normal chemical 
Fig. 1. New bone formation. Arrows indicate the foci of new bone formation. Bone formation of Grade 3 in Adcon-L and Grade 2 in control group 
are shown (HE, x10). Both agents reduce the fibroblast density significantly (MT, x10). Inflammatory cell density is significantly lower in the 
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pathways followed in DNA synthesis.[13,23,24] On the oth-
er hand, Adcon-L is comprised of polyglycan esters and a 
gelatin that can be absorbed within a phosphate-buffered 
solution. Its primary mechanism of action is as a mechani-
cal barrier against the migrating fibroblasts.[25]
Histological examination suggested that both agents 
affect the healing process over the operation site. Both 
agents were found to reduce the fibrotic tissue. However, 
there was a significant difference between 5FU and Ad-
con-L with regard to bone formation. Although we can-
not explain the reason behind this significant difference, 
the delay concerning the absorption of Adcon-L appears 
to have a different influence over the healing process. In 
our study, Adcon-L failed to be absorbed in half of the 
samples in the Adcon-L group. Zou et al.[11] obtained a 
similar result. However, the significant elevation in the 
number of inflammatory cells in our study may be as-
sociated with the delayed absorption of Adcon-L and 
the antigenic properties of Adcon-L particles. Another 
factor that may explain this difference is the above de-
scribed action mechanism of the two agents.
Our study had some limitations, including the absence 
of manual and radiological assessments and complications 
in evaluation of movement between the two vertebrae due 
to the small size of the evaluated area.[26] In the present 
study, no graft substitute was employed. Therefore, no 
detectable fusion mass was determined in the posterior 
spine which made the observation of osseous bridging, 
both radiologically and manually, impossible.
In conclusion, 5FU was significantly superior to Ad-
con-L in the inhibition of fibroblasts, inflammatory cells 
and bone formation. These findings suggest that 5FU 
can successfully inhibit fusion, fibrosis, and unwanted 
healing tissue in spinal surgery. Although 5FU appears 
to be a promising agent in this regard, further studies 
outlining the appropriate dosage and technique concern-
ing its use on the human spine are necessary.
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